BARTHELEMY NICOLAS
SEC CIK 1283576 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Dir | 5,436 | $150.5K | $474.1K | 8 | 2021-10-29 | 2026-05-14 |
| TWST | Twist Bioscience Corp | Dir | 23.0K | $250.1K | — | 3 | 2022-02-08 | 2022-11-21 |
| MASS | 908 Devices Inc. | Dir | 15.4K | — | — | 1 | 2022-06-15 | 2022-06-15 |
| LAB | STANDARD BIOTOOLS INC. | Dir | 204.1K | — | — | 2 | 2022-03-31 | 2022-04-01 |
Most active insiders at RGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hunt Anthony | Dir | — | $7.01M |
| 2 | Loeillot Olivier | CEO, Dir | — | $4.19M |
| 3 | Bylund James | COO | — | $331.3K |
| 4 | Garland Jason K | CFO | — | $185.8K |
| 5 | DAWES KAREN A | Dir | — | $44.3K |
| 6 | Douglass Brian Robb | Chief PRODUCT Off | — | — |
| 7 | Pax Margaret | Dir | — | — |
| 8 | Hughes Violetta | CAO | — | — |
| 9 | Mhatre Rohin | Dir | — | — |
| 10 | Konstantinov Konstantin | Dir | — | — |
| 14 | BARTHELEMY NICOLAS | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-18 16:05 | 2026-05-14 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +995 | 5,436 | +22% | $0 |
| D | 2025-05-21 | 2025-05-15 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +973 | 4,441 | +28% | $0 |
| 2024-06-14 | 2024-06-14 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | P - Purchase | $125.45 | +1,200 | 4,668 | +35% | +$150.5K | |
| D | 2024-05-20 | 2024-05-16 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +701 | 3,468 | +25% | $0 |
| D | 2023-05-22 | 2023-05-18 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +686 | 2,767 | +33% | $0 |
| D | 2022-11-23 | 2022-11-21 | TWST | Twist Bioscience Corp | BARTHELEMY NICOLAS | Dir | M - OptEx | $23.33 | +9,082 | 23.0K | +65% | +$211.9K |
| D | 2022-06-17 | 2022-06-15 | MASS | 908 Devices Inc. | BARTHELEMY NICOLAS | Dir | M - OptEx | — | +1,379 | 15.4K | +10% | — |
| D | 2022-05-31 | 2022-05-26 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +534 | 2,081 | +35% | $0 |
| 2022-05-13 | 2022-05-11 | TWST | Twist Bioscience Corp | BARTHELEMY NICOLAS | Dir | P - Purchase | $29.25 | +8,550 | 13.9K | +159% | +$250.1K | |
| DI | 2022-04-04 | 2022-04-01 | LAB | STANDARD BIOTOOLS INC. | BARTHELEMY NICOLAS | Dir | M - OptEx | $3.74 | +21.0K | 204.1K | +11% | +$78.5K |
| DI | 2022-04-01 | 2022-03-31 | LAB | STANDARD BIOTOOLS INC. | BARTHELEMY NICOLAS | Dir | M - OptEx | $3.43 | +5,000 | 183.1K | +3% | +$17.1K |
| 2022-02-10 | 2022-02-08 | TWST | Twist Bioscience Corp | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +3,491 | 5,389 | +184% | $0 | |
| DM | 2021-11-02 | 2021-10-29 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | S - Sale+OE | $288.20 | -1,645 | 1,907 | -46% | -$474.1K |
| D | 2021-11-02 | 2021-10-29 | RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Dir | M - OptEx | $128.18 | +1,285 | 3,192 | +67% | +$164.7K |
Purchase Sale Sale after option exercise All abbreviations